Methods of Detecting and Identifying Both Known and Novel Influenza Viruses

This invention describes materials and methods of detecting novel influenza virus in a sample. As highlighted by the recent H1N1 pandemic strain, influenza viruses are constantly evolving and novel reassortments can quickly spread around the world.

The reagents and methods of this particular technology are capable of detecting any type of influenza virus (such as influenza A virus, influenza B virus, and influenza C virus) in a sample, including novel or previously unknown influenza viruses. Such methods and compositions are useful for diagnosing influenza virus infection in humans and animals.

Potential Commercial Applications:		Competitive Advantages:
Method of rapid, accurate subtype-screening of influenza viruses using "pan-influenza" RT-PCR Diagnostic tool for clinicians, veterinarians, public health programs, food-safety officials, researchers and forensic scientists		A full-spectrum, sensitive and specific assay for identification of influenza viruses, known and novel Easily adaptable for commercial production

Development Stage:

• Pre-clinical
• In vitro data available

Inventors:

Suxiang (Sue) Tong (CDC)  ➽ more inventions...


Intellectual Property:
U.S. Pat: 9,803,251 issued 2017-10-31
PCT Application No. PCT/US2013/029600
US Application No. 14/398,383

Publications:
Fouchier RA, et al. PMID 15709000
Fouchier RA, et al. PMID 11060074
Tong S, et al. PMID 18579717

Collaboration Opportunity:
The Centers for Disease Control and Prevention (CDC) is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate or commercialize Methods of Detecting and Identifying Both Known and Novel Influenza Viruses. For collaboration opportunities, please contact Suzanne Shope at sshope@cdc.gov or 770-488-8613.


Licensing Contact:
Karen Surabian, J.D., M.B.A.
Email: karen.surabian@nih.gov
Phone: 301-594-9719

OTT Reference No: E-274-2013-0
Updated: Sep 18, 2013